Related Experiment Video
Updated: Jun 30, 2025

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Chylothorax: pathophysiology, diagnosis, and management-a comprehensive review
Malvika Bhatnagar1, Annette Fisher2, Sudarshan Ramsaroop3
1Department of Respiratory Medicine, South Tyneside and Sunderland NHS Foundation Trust, South Tyneside, UK.
Chylothorax, a rare buildup of chyle in the pleural space, requires prompt diagnosis and tailored management. Recognizing the cause of thoracic duct disruption is key to effective treatment strategies.
Area of Science:
- Medical Science
- Pulmonology
- Thoracic Surgery
Background:
- Chylothorax involves chyle accumulation in the pleural space, a rare condition with significant morbidity and mortality.
- Disruption of the thoracic duct, responsible for chyle transport, underlies chylothorax development.
- Causes range from iatrogenic trauma to non-traumatic conditions like malignancy and heart failure.
Purpose of the Study:
- To provide a comprehensive overview of chylothorax.
- To cover relevant anatomy, aetiology, pathophysiology, clinical features, diagnosis, and management.
- To emphasize the need for individualized management strategies due to diverse causes.
Main Methods:
- Review of relevant anatomy, aetiology, pathophysiology, clinical features, diagnosis, and management of chylothorax.
- Diagnostic criteria include pleural fluid analysis with elevated triglycerides (>110 mg/dL) and reduced cholesterol (<200 mg/dL).
- Imaging modalities like CT scans and lymphatic-specific investigations aid in identifying the chyle leak site and underlying cause.
Main Results:
- Clinical presentation varies based on chyle accumulation rate and causative condition.
- Diagnosis relies on specific pleural fluid triglyceride and cholesterol levels.
- Management is multifaceted, including conservative (diet, medication), interventional (embolization, ligation), and drainage approaches.
Conclusions:
- Individualized management is recommended due to diverse aetiological factors and patient characteristics.
- Chylothorax management is evolving, with a need for more high-quality evidence and standardized guidelines.
- A multidisciplinary approach is crucial for optimizing patient care in chylothorax cases.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

